Tandem Diabetes Care Announces Upcoming Conference Presentation
Tandem Diabetes Care (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference. The company's management will present an update on Tuesday, August 13, 2024, at 1:30 PM Eastern Time (10:30 AM Pacific Time).
The presentation will be webcast live and an archive recording will be available for 30 days afterwards. Interested parties can access the live webcast and archive through the 'Events & Presentations' section of Tandem Diabetes Care's Investor Center website at http://investor.tandemdiabetes.com.
Tandem Diabetes Care (Nasdaq: TNDM), un'azienda leader nella tecnologia per la consegna dell'insulina e nella gestione del diabete, ha annunciato la sua partecipazione alla 44ª Conferenza Annuale sulla Crescita di Canaccord Genuity. La direzione dell'azienda presenterà un aggiornamento martedì 13 agosto 2024, alle 13:30 ora orientale (10:30 ora del Pacifico).
La presentazione sarà trasmessa in diretta e una registrazione archiviata sarà disponibile per 30 giorni successivamente. Le parti interessate possono accedere alla trasmissione in diretta e all'archivio nella sezione 'Eventi & Presentazioni' del sito web del centro investitori di Tandem Diabetes Care all'indirizzo http://investor.tandemdiabetes.com.
Tandem Diabetes Care (Nasdaq: TNDM), una empresa líder en tecnología de entrega de insulina y atención del diabetes, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity. La dirección de la empresa presentará una actualización el martes 13 de agosto de 2024, a la 1:30 PM hora del Este (10:30 AM hora del Pacífico).
La presentación se transmitirá en vivo y una grabación archivada estará disponible durante 30 días después. Las partes interesadas pueden acceder a la transmisión en vivo y al archivo a través de la sección 'Eventos & Presentaciones' del sitio web del centro de inversores de Tandem Diabetes Care en http://investor.tandemdiabetes.com.
탠덤 다이어빗케어(Tandem Diabetes Care, Nasdaq: TNDM)는 인슐린 전달 및 당뇨 기술 분야의 선도적인 회사로서 카나코드 제뉴이티 제44회 연례 성장 컨퍼런스에 참가한다고 발표했습니다. 회사 경영진은 2024년 8월 13일 화요일, 동부 시간 오후 1시 30분 (태평양 시간 오전 10시 30분)에 업데이트를 발표할 예정입니다.
발표는 실시간 웹캐스트로 진행되며, 이후 30일 동안 기록된 아카이브를 이용할 수 있습니다. 관심 있는 분들은 http://investor.tandemdiabetes.com의 탠덤 다이어빗케어 투자자 센터 웹사이트의 '이벤트 및 발표' 섹션을 통해 실시간 웹캐스트와 아카이브에 접근할 수 있습니다.
Tandem Diabetes Care (Nasdaq: TNDM), une entreprise leader dans la livraison d'insuline et la technologie pour le diabète, a annoncé sa participation à la 44ème Conférence Annuelle sur la Croissance de Canaccord Genuity. La direction de l'entreprise présentera une mise à jour le mardi 13 août 2024, à 13 h 30, heure de l'Est (10 h 30, heure du Pacifique).
La présentation sera diffusée en direct et un enregistrement archivé sera disponible pendant 30 jours par la suite. Les parties intéressées peuvent accéder au webinaire en direct et à l'archive dans la section 'Événements & Présentations' du site Web du Centre des Investisseurs de Tandem Diabetes Care à l'adresse http://investor.tandemdiabetes.com.
Tandem Diabetes Care (Nasdaq: TNDM), ein führendes Unternehmen im Bereich Insulinabgabe und Diabetes-Technologie, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity bekannt gegeben. Das Management des Unternehmens wird ein Update am Dienstag, den 13. August 2024 um 13:30 Uhr Eastern Time (10:30 Uhr Pacific Time) präsentieren.
Die Präsentation wird live übertragen und eine aufgezeichnete Archivaufnahme wird für 30 Tage danach verfügbar sein. Interessierte Parteien können über den Bereich 'Veranstaltungen & Präsentationen' der Investoren-Website von Tandem Diabetes Care unter http://investor.tandemdiabetes.com auf die Live-Übertragung und das Archiv zugreifen.
- None.
- None.
The presentation will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240730533019/en/
Media Contact:
858-366-6900
media@tandemdiabetes.com
Investor Contact:
858-366-6900
IR@tandemdiabetes.com
Source: Tandem Diabetes Care, Inc.
FAQ
When is Tandem Diabetes Care (TNDM) presenting at the Canaccord Genuity Growth Conference?
How can I watch Tandem Diabetes Care's (TNDM) presentation at the Canaccord Genuity conference?
How long will the archive of Tandem Diabetes Care's (TNDM) conference presentation be available?
What type of update will Tandem Diabetes Care (TNDM) provide at the Canaccord Genuity conference?
